Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Feb 2026, 20:14:40 UTC
Prior SEC filing
10 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
AMBERJACK CAPITAL PARTNERS, L.P., By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Managing Partner

Key filing fact

Amberjack Capital Partners, L.P. filed Form 4 for Innovex International, Inc. (INVX) on 27 Feb 2026.

Key facts

  • This page summarizes Amberjack Capital Partners, L.P.'s Form 4 filing for Innovex International, Inc. (INVX).
  • 6 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Feb 2026, 20:14.

Change

  • Previous filing in this sequence was filed on 10 Sep 2024.
  • Current net transaction value: -$162,609,971.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (9)

CIK 0002026035 Primary reporting owner

Amberjack Capital Partners, L.P.

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
AMBERJACK CAPITAL PARTNERS, L.P., By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Managing Partner
Signature date
27 Feb 2026
CIK 0002026029

Amberjack Capital Associates II, LLC

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
AMBERJACK CAPITAL FUND II, L.P., By: Amberjack Capital GP II, L.P., its general partner, By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026
CIK 0001944811

Amberjack Capital Fund II, L.P.

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
AMBERJACK CAPITAL GP II, L.P., By: Amberjack Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026
CIK 0002026032

Amberjack Capital GP II, L.P.

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
AMBERJACK CAPITAL ASSOCIATES II, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026
CIK 0002026027

Innovex Co-Invest Associates, LLC

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
AMBERJACK MANAGEMENT, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026
CIK 0002026028

Innovex Co-Invest Fund II GP, L.P.

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
JASON TUROWSKY, /s/ Jason Turowsky
Signature date
27 Feb 2026
CIK 0001958403

Innovex Co-Invest Fund II, L.P.

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
INNOVEX CO-INVEST FUND II, L.P., By: Innovex Co-Invest Fund II GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026
CIK 0002025157

Turowsky Jason

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
INNOVEX CO-INVEST FUND II GP, L.P., By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026
CIK 0002026020

Amberjack Management, LLC

Relationship
Director, 10%+ Owner
Address
4400 POST OAK PARKWAY, SUITE 2760, HOUSTON
Signature
INNOVEX CO-INVEST ASSOCIATES, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Signature date
27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVX transaction

Common Stock

Sale

Transaction value
$120,552,553
Shares
-4,902,244
Change %
-23%
Price
$24.59
Shares after
16,871,374
Date
27 Feb 2026
Ownership
By Amberjack Capital Fund II, L.P.
Footnotes
F1, F7, F8, F9, F10
INVX transaction

Common Stock

Sale

Transaction value
$28,148,063
Shares
-1,144,635
Change %
-23%
Price
$24.59
Shares after
3,939,330
Date
27 Feb 2026
Ownership
By Innovex Co-Invest Fund II, L.P.
Footnotes
F2, F7, F8, F9, F10
INVX transaction

Common Stock

Sale

Transaction value
$6,671,103
Shares
-271,279
Change %
-23%
Price
$24.59
Shares after
933,624
Date
27 Feb 2026
Ownership
By Innovex Co-Invest Fund, L.P.
Footnotes
F3, F7, F8, F9, F10
INVX transaction

Common Stock

Sale

Transaction value
$5,754,586
Shares
-234,009
Change %
-23%
Price
$24.59
Shares after
805,355
Date
27 Feb 2026
Ownership
By Intervale Capital Fund II, L.P.
Footnotes
F4, F7, F8, F9, F10
INVX transaction

Common Stock

Sale

Transaction value
$2,853
Shares
-116
Change %
-23%
Price
$24.59
Shares after
399
Date
27 Feb 2026
Ownership
By Intervale Capital Fund II-A, L.P.
Footnotes
F5, F7, F8, F9, F10
INVX transaction

Common Stock

Sale

Transaction value
$1,480,814
Shares
-60,217
Change %
-23%
Price
$24.59
Shares after
207,240
Date
27 Feb 2026
Ownership
By Intervale Capital Fund III, L.P.
Footnotes
F6, F7, F8, F9, F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

Footnote F2

Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

Footnote F3

Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

Footnote F4

Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

Footnote F5

Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

Footnote F6

Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.

Footnote F7

The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.

Footnote F8

(Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".

Footnote F9

By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.

Footnote F10

(Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.

SEC remarks

This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The first of two Forms 4 was filed by the designated filer Innovex Co-Invest Fund, L.P.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .